+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography



Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography



Biochemical and Biophysical Research Communications 167(3): 1122-1127



A part of low density lipoproteins (LDL) isolated from the blood of healthy subjects and patients with coronary atherosclerosis bind to a Sepharose-linked Ricinus communis agglutinin, a lectin that interacts specifically with galactose residues. Bound LDL can be replaced by galactose, but not other saccharide constituents of the LDL molecule (mannose, glucose, N-acetylglucosamine, sialic acid). Bound LDL subfraction has a 2-3-fold lower content of sialic acid as compared with unbound LDL. The blood content of desialylated LDL in atherosclerotic patients was about 3-fold higher (1.5- to 6-fold) than in healthy subjects. Desialylated LDL induced a 2- to 4-fold more intensive accumulation of total cholesterol in cultured human aortic intimal cells. Unbound LDL had no effect on intracellular deposition of lipids. It is suggested that the subfraction of desialylated LDL may be responsible for the atherogenicity of LDL isolated from blood of atherosclerotic patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040522579

Download citation: RISBibTeXText

PMID: 2322261

DOI: 10.1016/0006-291x(90)90639-5


Related references

Desialylated low density lipoprotein naturally occurring modified lipoprotein with atherogenic potency. Atherosclerosis 86(2-3): 153-162, 1991

Desialylated low density lipoprotein naturally occurring modified lipoprotein in the blood of patients with coronary atherosclerosis. Byulleten' Eksperimental'noi Biologii i Meditsiny 110(8): 138-140, 1990

Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochemical and Biophysical Research Communications 162(1): 206-211, 1989

Isolation of desialylated low density lipoproteins from the blood of chd patients by affinity chromatography. Byulleten' Eksperimental'noi Biologii i Meditsiny 110(12): 606-609, 1990

Isolation of desialylated low-density lipoproteins from blood of coronary heart disease patients by affinity chromatography. Bulletin of Experimental Biology and Medicine 110(6): 1654-1657, 1990

Isolation of desialylated low density lipoproteins from the blood of patients with ischemic heart disease by affinity chromatography. Biulleten' Eksperimental'noi Biologii i Meditsiny 110(12): 606-609, 1990

Multiple-modified Low-Density Lipoprotein as Atherogenic Factor of Patients' Blood: Development of Therapeutic Approaches to Reduce Blood Atherogenicity. Current Pharmaceutical Design 23(6): 932-936, 2017

Factors responsible for atherogenic potential of blood plasma modified low density lipoprotein ldl and autoantibodies against modified ldl. European Journal of Clinical Investigation 19(2 Part 2): A77, 1989

Interaction of native and modified low density lipoprotein with intimal cells in atherosclerotic lesion. Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia .(1): 109-117, 2013

Atherogenic factors of blood serum i modified low density lipoprotein. Circulation 80(4 Suppl. 2): II161, 1989

Low Very low-Density Lipoprotein Cholesterol but High Very low-Density Lipoprotein Receptor mRNA Expression in Peripheral White Blood Cells: An Atherogenic Phenotype for Atherosclerosis in a Community-Based Population. Ebiomedicine 25: 136-142, 2017

Detection of new epitopes formed upon oxidation of low density lipoprotein lipoprotein a and very low density lipoprotein use of an antiserum against 4 hydroxynonenal modified low density lipoprotein. Biochemical Journal 265(2): 605-608, 1990

Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients. International Angiology 13(1): 78-83, 1994

A novel procedure for the separation of high-density lipoprotein subspecies by affinity chromatography. Biochemical Society Transactions 17(1): 152-153, 1989

Isolation of hens egg yolk low density lipoprotein by affinity chromatography. Agricultural and biological chemistry 44(6): 1409-1410, 1980